HeartBeam appoints Robert Eno as President effective Jan 18, 2023

HeartBeam, Inc.

Robert Eno appointed as President effective Jan 18, 2023, a newly created role.
Annual salary of $360,000; eligible for incentive bonus up to 40% of base salary.
Granted option to purchase 240,000 shares of common stock under 2022 Stock Plan.
Eno brings 28+ years medical tech experience; previously CEO of PreView Medical, SVP Marketing at HeartFlow.
No family relationships or related party transactions with current officers/directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert P. Eno

President

BEAT · HeartBeam, Inc.

Effective: 2023-01-18
Filed: January 24, 2023, 6:59 PM ET

On January 18, 2023, the Board of Directors (the “ Board ”) of HeartBeam, Inc. (the “ Company ”) appointed Robert P. Eno as President of the Company (the “ Appointment ”) effective as of January 18, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert P. Eno was appointed as President at HeartBeam, Inc..

Action: appointed
Role: President

Exact text from the filing

On January 18, 2023, the Board of Directors (the “ Board ”) of HeartBeam, Inc. (the “ Company ”) appointed Robert P. Eno as President of the Company (the “ Appointment ”) effective as of January 18, 2023.

View on SEC.gov

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001779372-23-000001

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.